Product-focused roadmap shows how MSC secretomes can become scalable, standardized, GMP-ready biotherapeutics.
Industrial yeasts are a powerhouse of protein production, used to manufacture vaccines, biopharmaceuticals, and other useful ...
The Canadian government's recent approval of the first gene-edited animal to enter the food system has reignited debates over ...
According to Precedence Research, the global bioengineering market size will grow from USD 347.04 billion in 2026 to nearly USD 1,484.98 billion by 2035, with a healthy CAGR of 17.53% between 2026 and ...
Science] can be a threat to development and social justice aspirations, as capitalism tries to privatise knowledge, but it also can be an instrument of liberation and development insofar as the ...
Though transhumanism presents ground-breaking advancements, it challenges ethical and societal values. The integration of ...
Back in early 2023, the dodo's genome was sequenced from a DNA sample. Now the company trying to resurrect the long-extinct flightless bird is working with Mauritian conservationists to restore ...
AL AIN, 16th December, 2025 (WAM) -- The Khalifa Centre for Genetic Engineering & Biotechnology (KCGEB) continues to drive the UAE’s leadership in genomics and biotechnology by transforming scientific ...
Changing an organism’s genome is a profound act, and the tools you use to make the changes don’t alleviate the need for responsible regulation. Unlike “traditional” genetically modified organisms (GMO ...
An international team of researchers has used genetic engineering to create the first ever “product-ready” antivenom for snakes such as cobras and mambas. The groundbreaking research is published in ...
At a meeting of top conservation groups this week, a bioethics question took center stage: Should scientists be allowed to tinker with the genes of wild plants and animals? The tentative consensus so ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results